Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE-2) (R61/R33 Clinical Trial Required)

This Funding Opportunity Announcement (FOA) is specifically designed to address the gap in translation by expediting the delivery of evidence-based HLBS interventions by supporting research that employs implementation frameworks to develop and test implementation strategies for EBP that are sustainable beyond the period of external research funding and which are transferable to other end-use stakeholders. The FOA supports pragmatic milestone-driven, single-site, biphasic, late-stage (T4) translation and implementation research projects which propose to identify and test adaptable implementation strategies that will increase the scale-up and sustainable use of EBPs for preventing and/or managing HLBS disorders. For the purpose of this FOA, late-stage translation and implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions into routine clinical, or public health practice and/or community-based settings to improve health. The FOA also supports the development and dissemination of the implementation strategy plan which may include re-usable infrastructure, e.g., national standards for data extraction and interoperability, so that others may adapt the implementation strategy(ies) and replicate sustainable success.